Market Risers: Burberry Group plc, AstraZeneca plc, Centrica PLC, Admiral Group plc, RSA Insurance Group plc & Compass Group plc

Burberry Group PLC
[shareaholic app="share_buttons" id_name="post_below_content"]

The stock price for Burberry Group plc ticker lookup code: LON:BRBY has climbed 2.3% or 38.5 points during today’s session so far. Market buyers have stayed positive during the trading session. The periods high has already touched 1727 and a low of 1682.5. The number of shares traded by this point in time totalled 513,282 with the daily average number around 2,856,806. The 52 week high price for the shares is 2338 amounting to 667.5 points different to the previous business close and a 52 week low sitting at 1481.5 making a difference of 189 points. Burberry Group plc now has a 20 moving average of 1882.25 and now its 50 day moving average at 2065.59. This puts the market cap at £6,954.99m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Burberry Group plc being recorded at Wednesday, October 24, 2018 at 12:06:18 PM GMT with the stock price trading at 1709 GBX.

 

The trading price for AstraZeneca plc with EPIC code: LON:AZN has gained 1.58% or 94 points during the course of today’s session so far. Traders seem confident throughout the trading session. The high for the period has reached 6033 while the low for the session was 5946. The number of shares traded by this point in time totalled 385,981 whilst the daily average number of shares exchanged is just 2,360,963. The 52 week high is 6126.4 which is 195.4 points in difference on the previous days close and a 52 week low being 4544.5 which is a difference of 1386.5 points. AstraZeneca plc has a 20 day moving average of 5901.1 and now the 50 day moving average now of 5854.24. The market cap now stands at £75,512.62m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Wednesday, October 24, 2018 at 12:06:15 PM GMT with the stock price trading at 6025 GBX.

 

Shares of Centrica PLC with company EPIC: LON:CNA has increased 1.49% or 2.2 points throughout today’s trading session so far. Buyers seem confident during this period. Range high for the period so far is 150.72 while the low for the session was 148.15. The total volume of shares exchanged so far has reached 5,888,626 with the daily average number around 28,023,884. The 52 week high price for the shares is 175.9 which comes in at 27.85 points difference from the previous days close and the 52 week low at 123.1 a difference of some 24.95 points. Centrica PLC has a 20 SMA of 151.33 and also a 50 day moving average at 149.08. The market capitalisation is now £8,365.36m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Centrica PLC being recorded at Wednesday, October 24, 2018 at 12:06:02 PM GMT with the stock price trading at 150.25 GBX.

 

The stock price for Admiral Group plc EPIC code: LON:ADM has stepped up 1.96% or 38.5 points in today’s trading session so far. Market buyers are a positive bunch during the trading session. The periods high has already touched 2010 while the low for the session was 1967. Volume total for shares traded at this point reached 88,718 with the daily average at 939,008. The 52 week high for the share price is 2138 some 172.5 points difference from the previous days close and the 52 week low at 1794.5 a difference of some 171 points. Admiral Group plc has a 20 day moving average of 2033.75 and also a 50 day SMA of 2053.22. Market capitalisation is now £5,658.98m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Admiral Group plc being recorded at Wednesday, October 24, 2018 at 12:04:48 PM GMT with the stock price trading at 2004 GBX.

 

Shares in RSA Insurance Group plc company symbol: LON:RSA has climbed 1.29% or 7 points during the course of today’s session so far. Buyers are a positive bunch during this period. The periods high figure was 551.8 while the low for the session was 543.8. The number of shares traded by this point in time totalled 530,086 with the daily average number around 5,348,018. The 52 week high for the shares is 683.4 some 139.8 points difference from the previous days close and putting the 52 week low at 537.8 a difference of some 5.80 points. RSA Insurance Group plc now has a 20 simple moving average of 577.19 and a 50 day simple moving average now of 608.57. Market capitalisation is now £5,589.99m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for RSA Insurance Group plc being recorded at Wednesday, October 24, 2018 at 12:05:00 PM GMT with the stock price trading at 550.6 GBX.

 

The trading price for Compass Group plc EPIC code: LON:CPG has risen 1.99% or 29.5 points during the course of today’s session so far. Traders seem confident during this period. The period high was 1513.5 dropping as low as 1485.5. The amount of shares exchanged has so far reached 523,595 with the daily average traded share volume around 3,981,414. The 52 week high is 1722 which is 239 points in difference on the previous days close and a 52 week low being 1396.5 making a difference of 86.5 points. Compass Group plc now has a 20 SMA of 1612.55 and also a 50 day simple moving average now at 1643.38. Market capitalisation is now £23,711.56m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Compass Group plc being recorded at Wednesday, October 24, 2018 at 12:05:43 PM GMT with the stock price trading at 1512.5 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.
    AstraZeneca's Wainzua gains CHMP backing for EU approval in treating ATTRv-PN, marking a potential breakthrough with self-administered therapy.

      Search

      Search